Efficacy and tolerability of intravenous ferric gluconate in the treatment of iron deficiency anemia in patients without kidney disease

Archives of Internal Medicine

Volumn 167, Issue 12, 2007, Pages 1327-1328

  Miller, Heather J ^a   Hu, James ^b   Valentine, Johanna K ^b   Gable, Preston S ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FERRIC GLUCONATE; FERRITIN; HEMOGLOBIN;

ADULT; BACK SPASM; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DYSPNEA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART PALPITATION; HEMATOCRIT; HUMAN; IRON DEFICIENCY ANEMIA; KIDNEY DISEASE; LABORATORY TEST; LETTER; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MEAN CORPUSCULAR VOLUME; MUSCLE SPASM; NECK SPASM; PRIORITY JOURNAL; PRURITUS; RANK SUM TEST; STOMACH BYPASS; URTICARIA; UTERUS BLEEDING;

ANEMIA, IRON-DEFICIENCY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FERRIC COMPOUNDS; FERRITINS; FOLLOW-UP STUDIES; HEMATINICS; HEMATOCRIT; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34347229739     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.12.1327     Document Type: Letter

References (6)

1. Faich G, Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextran. Am J Kidney Dis. 1999;33:464-470.
2. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the US. JAMA. 1997;277:973-976.
3. Cook JD. Diagnosis and management of iron-deficiency anemia. Best Pract Res Clin Haematol. 2005;18:319-332.
4. Eichbaum Q, Foran S, Dzik S. Is iron gluconate really safer than iron dextran? Blood. 2003;101:3756-3757.
5. Maslovsky I. Intravenous iron in a primary-care clinic. Am J Hematol. 2005;78:261-264.
6. Hamstra RD, Block MH, Schokert AL. Intravenous iron dextran in clinical medicine. JAMA. 1980;243:1726-1731.